NCT02900040 Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation
| NCT ID | NCT02900040 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Kidney Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 1994-01 |
| Primary Completion | 2050-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 1994-01 with a primary completion date of 2050-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The French DIVAT (standing for Données Informatisées et VAlidées en Transplantation in french, and in English "Computerized and VAlidated Data in Transplantation" ) cohort was Kicked off in 1994 by the Transplantation Urology Nephrology Institute of the Nantes University Hospital in France. The primary objective of this multicenter computerized database was to enable prospective clinical and epidemiological research studies concerning kidney transplant recipients, particularly focusing on mid- and long-term clinical outcomes, therapeutic strategies and public health issues. The patient-case system of the DIVAT cohort allows the monitoring of medical records of all patient-specific and allograft-specific data, including bio-banking since 2005. Data are collected from the date of transplantation until the graft failure, at each scheduled outpatient visit or hospital admission motivating by a new clinical, therapeutical or biological expression. The DIVAT cohort contains information on more than 11000 transplant recipients between 1994 and today, issued from 8 French university hospitals centers (the DIVAT Network is organized by a consortium agreement). 18% of all patients underwent retransplantation and 11% of all kidney transplants originated from living donors. The DIVAT network heavily works to ensure a high-quality data collection with the aim of exploring adequately the complex post-transplantation process. The Divat network encourage collaborations and enables interested researchers to submit a research project by completing a request form available on the DIVAT website (http://www.divat.fr/en) describing the context, objectives and design of the study
Eligibility Criteria
Inclusion Criteria: * over the age of 18 years * with renal transplant Exclusion Criteria: * minor * pediatric transplantation
Contact & Investigator
Magali Giral, PU-PH
PRINCIPAL INVESTIGATOR
Nantes Universuty Hospital
Frequently Asked Questions
Who can join the NCT02900040 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02900040 currently recruiting?
Yes, NCT02900040 is actively recruiting participants. Contact the research team at mgiral@chu-nantes.fr for enrollment information.
Where is the NCT02900040 trial being conducted?
This trial is being conducted at Lyon, France, Montpellier, France, Nancy, France, Nancy, France and 4 additional locations.
Who is sponsoring the NCT02900040 clinical trial?
NCT02900040 is sponsored by Nantes University Hospital. The principal investigator is Magali Giral, PU-PH at Nantes Universuty Hospital. The trial plans to enroll 30,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.